Global Life Sciences Supply Chain Insights

Update: 2022-11-03

Description

Published in Chambers Expert Focus. Lauren Murdza and Richard Taylor share their insights on supply chain issues in the life sciences sector in the latest episode of At the Intersection of Science and Law.

See omnystudio.com/listener for privacy information.

Comments

In Channel

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

2024-11-1529:38

Life sciences companies and the risks posed by the mifepristone litigation

2023-05-1933:18

Trade secrets protection in the life sciences sector

2023-04-1221:23

Cross-border considerations for privacy in clinical trials

2023-02-0618:19

Global Life Sciences Supply Chain Insights

2022-11-0327:36

AI risk assessments: Future-proofing your innovation when rules can change mid-game

2022-09-0624:43

The rise of global telehealth

2022-06-0125:35

Advising the advisor: Tips for navigating the life sciences and regulatory environment

2022-04-1831:00

The moral imperative: Balancing innovation, regulation and prescription drug availability

2022-03-2130:31

Incentivizing diverse representation in clinical trials

2022-03-0222:40

The crossroad of science and law

2021-12-1626:17

Social media’s impact on the life sciences industry

2021-11-0834:50

Understanding AI and its use in drug discovery

2021-10-0531:49

mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

2021-09-0326:25

00:00

Global Life Sciences Supply Chain Insights

#box-pro-ellipsis-17577843449520{-webkit-line-clamp:2;}Global Life Sciences Supply Chain Insights

Global Life Sciences Supply Chain Insights

DLA Piper

Global Life Sciences Supply Chain Insights